Insider Transactions Reported by 20 Insiders of Nkarta, Inc.

Symbol
NKTX on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Nkarta, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James Trager Chief Scientific Officer $845,370 18 Jun 2024
Paul J. Hastings Chief Executive Officer, Director $807,347 -$57,119 -6.6% 15 Jan 2026
David Shook Chief Medical Officer, Head of Research & Development $420,101 15 Jan 2025
Nadir Mahmood President $347,194 -$11,693 -3.3% 15 Jan 2026
Alicia J. Hager Chief Legal Officer $322,817 15 Jan 2025
Ralph Brandenberger Chief Technical Officer $274,551 15 Jan 2025
Alyssa Levin Chief Financial and Business Officer $225,856 15 Jan 2025
Shawn Marshall Rose Chief Medical Officer, Head of Research & Development $134,169 06 Jan 2026
Kanya Rajangam Chief Medical Officer $111,872 14 Jan 2022
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner 05 Jun 2025
Laura Shawver Director 08 Jun 2022
Zachary Scheiner Director 05 Jun 2025
Angela Thedinga Director 05 Jun 2025
Michael Dybbs Director 05 Jun 2025
Ali Behbahani Director 05 Jun 2025
Tiba Aynechi Director 08 Jun 2022
Leone D. Patterson Director 05 Jun 2025
George Vratsanos Director 05 Jun 2025
Simeon George Director 05 Jun 2025
Fouad Oscar Azzam Director 07 Jun 2023

Recent Insider Transactions by Companies or Individuals for Nkarta, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Paul J. Hastings NKTX Common Stock Sale -6.26% $53,915 $2.07 -26,046 390,023 15 Jan 2026 Direct
Nadir Mahmood NKTX Common Stock Sale -3.26% $11,693 $2.07 -5,649 167,727 15 Jan 2026 Direct
Shawn Marshall Rose NKTX Common Stock Award 70,000 70,000 06 Jan 2026 Direct
Shawn Marshall Rose NKTX Stock Option (right to buy) Award 139,000 139,000 06 Jan 2026 Direct
Nadir Mahmood NKTX Common Stock Award 85.7% 80,000 173,376 06 Jan 2026 Direct
Nadir Mahmood NKTX Stock Option (right to buy) Award 160,000 160,000 06 Jan 2026 Direct
Paul J. Hastings NKTX Common Stock Award 29.2% 94,000 416,069 06 Jan 2026 Direct
Paul J. Hastings NKTX Stock Option (right to buy) Award 562,000 562,000 06 Jan 2026 Direct
Shawn Marshall Rose NKTX Stock Option (right to buy) Award 500,000 500,000 23 Jun 2025 Direct
Paul J. Hastings NKTX Common Stock Sale -0.56% $3,204 $1.79 -1,790 320,069 18 Jun 2025 Direct
Simeon George NKTX Stock Option (right to buy) Award 46,000 46,000 05 Jun 2025 Direct
Ali Behbahani NKTX Stock Option (right to buy) Award 46,000 46,000 05 Jun 2025 Direct
Ra Capital Management, L.P. NKTX Stock Option (right to buy) Award 46,000 46,000 05 Jun 2025 See Footnotes
Nadir Mahmood NKTX Stock Option (right to buy) Award 123,500 123,500 05 Jun 2025 Direct
Paul J. Hastings NKTX Stock Option (right to buy) Award 377,000 377,000 05 Jun 2025 Direct
George Vratsanos NKTX Stock Option (right to buy) Award 46,000 46,000 05 Jun 2025 Direct
Angela Thedinga NKTX Stock Option (right to buy) Award 46,000 46,000 05 Jun 2025 Direct
Zachary Scheiner NKTX Stock Option (right to buy) Award 46,000 46,000 05 Jun 2025 Direct
Leone D. Patterson NKTX Stock Option (right to buy) Award 46,000 46,000 05 Jun 2025 Direct
Michael Dybbs NKTX Stock Option (right to buy) Award 46,000 46,000 05 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.